» Articles » PMID: 23507718

Utilization Patterns and Outcomes Associated with Central Venous Catheter in Septic Shock: a Population-based Study

Overview
Journal Crit Care Med
Date 2013 Mar 20
PMID 23507718
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: In 2001, a randomized trial showed decreased mortality with early, goal-directed therapy in septic shock, a strategy later recommended by the Surviving Sepsis Campaign. Placement of a central venous catheter is necessary to administer goal-directed therapy. We sought to evaluate nationwide trends in: 1) central venous catheter utilization and 2) the association between early central venous catheter insertion and mortality in patients with septic shock.

Design: We retrospectively analyzed the proportion of septic shock cases receiving an early (day of admission) central venous catheter and the odds of hospital mortality associated with receiving early central venous catheter from years 1998 to 2001 compared with 2002 to 2009.

Setting: Non-federal acute care hospitalizations from the Nationwide Inpatient Sample, 1998-2009.

Patients: A total of 203,481 (population estimate: 999,545) patients admitted through an emergency department with principal diagnosis of septicemia and secondary diagnosis of shock.

Interventions: None.

Measurements And Main Results: From 1998 to 2009, population-adjusted rates of septic shock increased from 12.6 cases per 100,000 U.S. adults to 78 cases per 100,000. During this time, age-adjusted hospital mortality associated with septic shock declined from 40.4% to 31.4%. Early central venous catheter insertion increased from 5.7% (95% confidence interval 5.1% to 6.3%) to 19.2% (95% confidence interval 18.7% to 19.5%) cases with septic shock, with an increased rate of early central venous catheter placement identified after 2007. The rate of decline in age-adjusted hospital mortality was significantly greater for patients who received an early central venous catheter (-4.2% per year, 95% confidence interval -3.2, -4.2%) as compared with no central venous catheter (-2.9% per year, 95% confidence interval -2.3, -3.5%; p = 0.016). Hospital mortality associated with early central venous catheter insertion significantly decreased from a multivariable-adjusted odds ratio of 1.29 (95% confidence interval 1.14-1.45) prior to 2001 to an adjusted odds ratio of 0.87 (95% confidence interval 0.84-0.90) after 2001.

Conclusions: Placement of a central venous catheter early in septic shock has increased three-fold since 1998. The mortality associated with early central venous catheter insertion decreased after publication of evidence-based instructions for central venous catheter use.

Citing Articles

The Study of the Feasibility of Ultrasound-guided Catheterization of the Right Brachiocephalic Vein in Adult Patients: A Prospective Observational Study.

Singh Y, Pratibhan M, Singh A, Depal V, Sawhney C, Gupta B J Med Ultrasound. 2024; 32(2):143-147.

PMID: 38882630 PMC: 11175376. DOI: 10.4103/jmu.jmu_57_23.


Unpacking Regionalization of Sepsis Care Using Hospital Capability Assessments.

Anesi G, Admon A Crit Care Med. 2023; 51(11):1594-1596.

PMID: 37902344 PMC: 10617649. DOI: 10.1097/CCM.0000000000005987.


Are patient volume and care level in teaching hospitals variables affecting clinical outcomes in adult intensive care units?.

Teixeira R, Oliveira J, Andrade M, Pinheiro F, Vieira R, Santana-Santos E Einstein (Sao Paulo). 2023; 21:eAO0406.

PMID: 37820201 PMC: 10519666. DOI: 10.31744/einstein_journal/2023AO0406.


CD19CD24CD38 regulatory B cells deficiency revealed severity and poor prognosis in patients with sepsis.

Wang C, Xu H, Gao R, Leng F, Huo F, Li Y BMC Immunol. 2022; 23(1):54.

PMID: 36357845 PMC: 9648441. DOI: 10.1186/s12865-022-00528-x.


Optimization of sepsis therapy based on patient-specific digital precision diagnostics using next generation sequencing (DigiSep-Trial)-study protocol for a randomized, controlled, interventional, open-label, multicenter trial.

Brenner T, Skarabis A, Stevens P, Axnick J, Haug P, Grumaz S Trials. 2021; 22(1):714.

PMID: 34663439 PMC: 8522064. DOI: 10.1186/s13063-021-05667-x.


References
1.
Lindenauer P, Lagu T, Shieh M, Pekow P, Rothberg M . Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009. JAMA. 2012; 307(13):1405-13. DOI: 10.1001/jama.2012.384. View

2.
Lagu T, Rothberg M, Shieh M, Pekow P, Steingrub J, Lindenauer P . What is the best method for estimating the burden of severe sepsis in the United States?. J Crit Care. 2012; 27(4):414.e1-9. DOI: 10.1016/j.jcrc.2012.02.004. View

3.
Suissa S . Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med. 2003; 168(1):49-53. DOI: 10.1164/rccm.200210-1231OC. View

4.
Wiener R, Welch H . Trends in the use of the pulmonary artery catheter in the United States, 1993-2004. JAMA. 2007; 298(4):423-9. DOI: 10.1001/jama.298.4.423. View

5.
Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6):1644-55. DOI: 10.1378/chest.101.6.1644. View